Histological Markers of Myelination in Demyelination Studies
Remyelination trials in multiple sclerosis are judged on imaging and functional endpoints because myelin cannot be examined directly in a patient. A...
Remyelination trials in multiple sclerosis are judged on imaging and functional endpoints because myelin cannot be examined directly in a patient. A...
Multiple sclerosis therapy has been transformed by agents that control inflammation, and the unmet need has shifted toward repair. Remyelination has...
Diabetic neuropathy affects nearly half of individuals living with diabetes, yet its underlying biological drivers remain only partially defined....
Experimental autoimmune encephalomyelitis (EAE) is one of the most widely used and well-characterized models for studying multiple sclerosis (MS)....
At this year’s Society for Neuroscience (SfN) meeting, our team presented a poster highlighting the advantages of using a porcine model to bridge the...
The Need for Diversity in Animal Models The clinical population is diverse, including both sexes, older individuals, and those with comorbid...
Enhancing clinical relevance in early-stage studies can improve efficiency, reduce costs, and guide critical decisions, ultimately advancing more CNS...
Parkinson’s Disease (PD) is a progressive neurodegenerative movement disorder that affects millions of people worldwide. PD is characterized by the...